These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38482096)

  • 21. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
    Dalton AF; Diallo AO; Chard AN; Moulia DL; Deputy NP; Fothergill A; Kracalik I; Wegner CW; Markus TM; Pathela P; Still WL; Hawkins S; Mangla AT; Ravi N; Licherdell E; Britton A; Lynfield R; Sutton M; Hansen AP; Betancourt GS; Rowlands JV; Chai SJ; Fisher R; Danza P; Farley M; Zipprich J; Prahl G; Wendel KA; Niccolai L; Castilho JL; Payne DC; Cohn AC; Feldstein LR; ;
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):553-558. PubMed ID: 37200229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake of Mpox vaccination among transgender people and gay, bisexual and other men who have sex with men among sexually-transmitted infection clinic clients in Vancouver, British Columbia.
    Gilbert M; Ablona A; Chang HJ; Grennan T; Irvine MA; Sarai Racey C; Salway T; Naus M; Dawar M; Ogilvie G
    Vaccine; 2023 Apr; 41(15):2485-2494. PubMed ID: 36894397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monkeypox virus-associated meningoencephalitis diagnosed by detection of intrathecal antibody production.
    Karin H; Ylva B; Sandra S; Aleksandra P; Per B; Klara S
    BMC Infect Dis; 2024 Jan; 24(1):94. PubMed ID: 38229022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018.
    Su JR; McNeil MM; Welsh KJ; Marquez PL; Ng C; Yan M; Cano MV
    Vaccine; 2021 Jan; 39(5):839-845. PubMed ID: 33422381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016.
    Myers TR; McNeil MM; Ng CS; Li R; Marquez PL; Moro PL; Omer SB; Cano MV
    Vaccine; 2020 Sep; 38(40):6291-6298. PubMed ID: 32747215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccine conspiracy association with higher COVID-19 vaccination side effects and negative attitude towards booster COVID-19, influenza and monkeypox vaccines: A pilot study in Saudi Universities.
    Alshehri S; Sallam M
    Hum Vaccin Immunother; 2023 Dec; 19(3):2275962. PubMed ID: 37941437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study.
    Yano R; Terada-Hirashima J; Uemura Y; Tomita N; Shimizu Y; Iwasaki H; Okumura N; Suzuki T; Saito S; Ujiie M; Sugiura W; Ohmagari N
    JMIR Res Protoc; 2023 Aug; 12():e46955. PubMed ID: 37624623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.
    Rosenberg ES; Dorabawila V; Hart-Malloy R; Anderson BJ; Miranda W; O'Donnell T; Gonzalez CJ; Abrego M; DelBarba C; Tice CJ; McGarry C; Mitchell EC; Boulais M; Backenson B; Kharfen M; McDonald J; Bauer UE
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):559-563. PubMed ID: 37339074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998.
    DuVernoy TS; Braun MM
    Pediatrics; 2000 Oct; 106(4):E52. PubMed ID: 11015547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptance and timeliness of post-exposure vaccination against mpox in high-risk contacts, Amsterdam, the Netherlands, May-July 2022.
    van Ewijk CE; Smit C; Bavalia R; Ainslie K; Vollaard A; van Rijckevorsel G; Hahné SJM
    Vaccine; 2023 Nov; 41(47):6952-6959. PubMed ID: 37838481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review.
    Geier MR; Geier DA
    Clin Exp Rheumatol; 2004; 22(6):749-55. PubMed ID: 15638050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of COVID-19 vaccine-induced myocarditis.
    Rose J; Hulscher N; McCullough PA
    Ther Adv Drug Saf; 2024; 15():20420986241226566. PubMed ID: 38293564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Major Birth Defects after Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990 to 2014.
    Moro PL; Cragan J; Lewis P; Sukumaran L
    Birth Defects Res; 2017 Jul; 109(13):1057-1062. PubMed ID: 28762675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak - United States, May 22-October 21, 2022.
    Duffy J; Marquez P; Moro P; Weintraub E; Yu Y; Boersma P; Donahue JG; Glanz JM; Goddard K; Hambidge SJ; Lewin B; Lewis N; Rouse D; Shimabukuro T
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(49):1555-1559. PubMed ID: 36480476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.
    Chang S; Ball R; Braun MM
    Vaccine; 2008 May; 26(19):2428-32. PubMed ID: 18406499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse event reports following vaccination for Lyme disease: December 1998-July 2000.
    Lathrop SL; Ball R; Haber P; Mootrey GT; Braun MM; Shadomy SV; Ellenberg SS; Chen RT; Hayes EB
    Vaccine; 2002 Feb; 20(11-12):1603-8. PubMed ID: 11858868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013.
    Sukumaran L; McNeil MM; Moro PL; Lewis PW; Winiecki SK; Shimabukuro TT
    Clin Infect Dis; 2015 May; 60(10):e58-65. PubMed ID: 25637587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994.
    Braun MM; Ellenberg SS
    J Pediatr; 1997 Oct; 131(4):529-35. PubMed ID: 9386653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.
    Farrar JL; Lewis NM; Houck K; Canning M; Fothergill A; Payne AB; Cohen AL; Vance J; Brassil B; Youngkin E; Glenn B; Mangla A; Kupferman N; Saunders K; Meza C; Nims D; Soliva S; Blouse B; Henderson T; Banerjee E; White B; Birn R; Stadelman AM; Abrego M; McLafferty M; Eberhart MG; Pietrowski M; De León SM; Creegan E; Diedhiou A; Wiedeman C; Murray-Thompson J; McCarty E; Marcinkevage J; Kocharian A; Torrone EA; Ray LC; Payne DC;
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(5152):1610-1615. PubMed ID: 36580416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007-2017.
    Moro PL; Arana J; Marquez PL; Ng C; Barash F; Hibbs BF; Cano M
    Vaccine; 2019 Jun; 37(28):3730-3734. PubMed ID: 31155414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.